🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/07/2021 | 78,01 | 78,38 | 77,63 | 78,02 | +0,15% | 0,96% | 7.638.200 |
| 15/07/2021 | 77,62 | 78,04 | 77,21 | 77,90 | +0,36% | 1,07% | 7.041.300 |
| 14/07/2021 | 77,60 | 77,72 | 76,88 | 77,62 | +0,01% | 1,08% | 7.163.200 |
| 13/07/2021 | 77,40 | 77,77 | 77,24 | 77,61 | +0,08% | 0,68% | 6.465.800 |
| 12/07/2021 | 77,55 | 78,43 | 77,39 | 77,55 | -0,56% | 1,34% | 11.087.900 |
| 09/07/2021 | 78,42 | 78,69 | 77,94 | 77,99 | -0,17% | 0,96% | 6.006.500 |
| 08/07/2021 | 77,77 | 78,30 | 77,31 | 78,12 | -0,56% | 1,27% | 8.400.400 |
| 07/07/2021 | 78,41 | 78,61 | 78,13 | 78,56 | +0,58% | 0,61% | 8.275.100 |
| 06/07/2021 | 78,14 | 78,35 | 77,56 | 78,11 | -0,62% | 1,01% | 6.720.500 |
| 02/07/2021 | 78,04 | 78,77 | 77,76 | 78,60 | +0,78% | 1,29% | 7.668.000 |
| 01/07/2021 | 77,65 | 78,15 | 77,51 | 77,99 | +0,28% | 0,82% | 9.212.000 |
| 30/06/2021 | 77,40 | 78,09 | 77,23 | 77,77 | +0,73% | 1,11% | 13.811.900 |
| 29/06/2021 | 77,00 | 77,33 | 76,82 | 77,21 | +0,46% | 0,66% | 7.696.600 |
| 28/06/2021 | 77,25 | 77,74 | 76,79 | 76,86 | -0,44% | 1,23% | 8.796.200 |
| 25/06/2021 | 76,06 | 77,97 | 76,05 | 77,20 | +1,10% | 2,52% | 50.285.200 |
| 24/06/2021 | 75,73 | 76,64 | 75,73 | 76,36 | +1,03% | 1,20% | 8.601.900 |
| 23/06/2021 | 75,85 | 76,26 | 75,55 | 75,58 | -0,80% | 0,94% | 9.539.100 |
| 22/06/2021 | 76,59 | 76,74 | 76,01 | 76,19 | -0,73% | 0,95% | 10.957.500 |
| 21/06/2021 | 76,89 | 77,29 | 76,55 | 76,75 | +0,18% | 0,96% | 10.880.800 |
| 18/06/2021 | 76,74 | 77,22 | 76,16 | 76,61 | -0,80% | 1,38% | 19.351.900 |
| 17/06/2021 | 76,34 | 77,47 | 75,99 | 77,23 | +0,81% | 1,94% | 14.233.200 |
| 16/06/2021 | 76,22 | 77,55 | 76,19 | 76,61 | +1,20% | 1,78% | 17.576.900 |
| 15/06/2021 | 75,50 | 75,77 | 74,72 | 75,70 | +0,33% | 1,39% | 14.185.700 |
| 14/06/2021 | 75,74 | 75,80 | 74,88 | 75,45 | -1,08% | 1,21% | 7.841.400 |
| 11/06/2021 | 76,71 | 76,86 | 75,61 | 76,27 | +0,17% | 1,63% | 13.928.400 |
| 10/06/2021 | 75,23 | 76,47 | 74,74 | 76,14 | +2,84% | 2,30% | 17.236.700 |
| 09/06/2021 | 73,00 | 74,30 | 72,95 | 74,04 | +2,27% | 1,85% | 12.258.700 |
| 08/06/2021 | 72,95 | 73,17 | 72,08 | 72,40 | -0,55% | 1,49% | 13.657.700 |
| 07/06/2021 | 74,14 | 74,20 | 72,78 | 72,80 | -1,77% | 1,92% | 16.794.400 |
| 04/06/2021 | 74,20 | 74,48 | 73,90 | 74,11 | +0,27% | 0,78% | 12.728.500 |